Announcements Trials
Browse Landscape

Phase

Phase 2 18Phase 1 11Phase 1/2 7Phase EARLY_PHASE1 1Phase 2/3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Pancreatic Neoplasms 5Sarcoma 2Prostatic Neoplasms 1Ovarian Neoplasms 1Neuroblastoma 1Gliosarcoma 1Glioblastoma 1Diffuse Intrinsic Pontine Glioma 1Desmoplastic Small Round Cell Tumor 1Colonic Neoplasms 1Central Nervous System Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1Borderline Resectable Pancreatic Adenocarcinoma 1

Interventions

Temozolomide 7Radiotherapy 6Bevacizumab 5Magnetic Resonance Spectroscopy 3ribociclib 2olaparib 2fluorodopa F 18 2fluciclovine F-18 2atezolizumab 2abemaciclib 2Surgical Procedures, Operative 2Specimen Handling 2Radiation 2Ketoconazole 2Everolimus 2Disulfiram 2Carvedilol 2zimberelimab 1tinostamustine 1temsirolimus 1senicapoc 1sacituzumab govitecan 1posaconazole 1pitavastatin 1perampanel 1pamiparib 1palbociclib 1niraparib 1mycophenolic adenine dinucleotide 1lorlatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Glioblastoma × Irinotecan × Clear all
NCT01086345 2018-07-03

Radiosurgery Plus Bevacizumab in Glioblastoma

Case Comprehensive Cancer Center

Phase EARLY_PHASE1 Terminated
9 enrolled
CNSSarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡